Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 1031794, 11 pages
http://dx.doi.org/10.1155/2016/1031794
Review Article

Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis

1Department of Cardiology, Zhu Jiang Hospital, Southern Medical University, Guangzhou 510280, China
2Department of Biostatistics, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, China
3Department of Cardiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510280, China
4Southern Medical University, Guangzhou 510515, China

Received 23 May 2015; Accepted 13 August 2015

Academic Editor: Armand Keating

Copyright © 2016 Bei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Jeevanantham, M. Butler, A. Saad, A. Abdel-Latif, E. K. Zuba-Surma, and B. Dawn, “Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis,” Circulation, vol. 126, no. 5, pp. 551–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Delewi, A. Hirsch, J. G. Tijssen et al., “Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis,” European Heart Journal, vol. 35, no. 15, pp. 989–998, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur, and S. M. Watt, “Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review,” European Heart Journal, vol. 29, no. 15, pp. 1807–1818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Bartunek, W. Wijns, G. R. Heyndrickx, and M. Vanderheyden, “Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S52–S56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B.-E. Strauer and G. Steinhoff, “10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice,” Journal of the American College of Cardiology, vol. 58, no. 11, pp. 1095–1104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Sürder, J. Schwitter, T. Moccetti et al., “Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI),” American Heart Journal, vol. 160, no. 1, pp. 58–64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Assmus, D. M. Leistner, V. Schächinger et al., “Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival,” European Heart Journal, vol. 35, no. 19, pp. 1275–1283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Traverse, T. D. Henry, C. J. Pepine et al., “Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial,” Journal of the American Medical Association, vol. 308, pp. 2380–2389, 2012. View at Google Scholar
  9. J. H. Traverse, T. D. Henry, S. G. Ellis et al., “Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial,” The Journal of the American Medical Association, vol. 306, no. 19, pp. 2110–2119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Leucht, A. Cipriani, L. Spineli et al., “Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis,” The Lancet, vol. 382, no. 9896, pp. 951–962, 2013. View at Publisher · View at Google Scholar
  11. P. Jüni, D. G. Altman, and M. Egger, “Systematic reviews in health care: assessing the quality of controlled clinical trials,” British Medical Journal, vol. 323, no. 7303, pp. 42–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Piepoli, D. Vallisa, M. Arbasi et al., “Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study),” European Journal of Heart Failure, vol. 12, no. 2, pp. 172–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Turan, T. I. Bozdag, C. H. Turan et al., “Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction,” Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 852–864, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Meluzín, S. Janoušek, J. Mayer et al., “Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction,” International Journal of Cardiology, vol. 128, no. 2, pp. 185–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wöhrle, F. von Scheidt, P. Schauwecker et al., “Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial,” Clinical Research in Cardiology, vol. 102, no. 10, pp. 765–770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Assmus, A. Rolf, S. Erbs et al., “Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction,” Circulation: Heart Failure, vol. 3, no. 1, pp. 89–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Dill, V. Schächinger, A. Rolf et al., “Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy,” American Heart Journal, vol. 157, no. 3, pp. 541–547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Schächinger, S. Erbs, A. Elsässer et al., “Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1210–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Cao, D. Sun, C. Li et al., “Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up,” European Heart Journal, vol. 30, no. 16, pp. 1986–1994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Plewka, M. Krzemińska-Pakuła, P. Lipiec et al., “Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 104, no. 10, pp. 1336–1342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Plewka, M. Krzemińska-Pakuła, J. Z. Peruga et al., “The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow−up results,” Kardiologia Polska, vol. 69, no. 12, pp. 1234–1240, 2011. View at Google Scholar · View at Scopus
  22. K. Yao, R. Huang, A. Sun et al., “Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction,” European Journal of Heart Failure, vol. 11, no. 7, pp. 691–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Grajek, M. Popiel, L. Gil et al., “Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial,” European Heart Journal, vol. 31, no. 6, pp. 691–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial,” Circulation, vol. 113, no. 10, pp. 1287–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. C. Wollert, G. P. Meyer, J. Lotz et al., “Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial,” The Lancet, vol. 364, no. 9429, pp. 141–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Castellani, A. Colombo, R. Giordano et al., “The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection,” Journal of Nuclear Medicine, vol. 51, no. 12, pp. 1908–1916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. R. Gao, X. T. Pei, Q. A. Ding et al., “A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction,” International Journal of Cardiology, vol. 168, no. 4, pp. 3191–3199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Colombo, M. Castellani, E. Piccaluga et al., “Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial,” Journal of Cardiovascular Medicine, vol. 12, no. 4, pp. 239–248, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Penicka, J. Horak, P. Kobylka et al., “Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study,” Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2373–2374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. B. D. S. Nogueira, S. A. Silva, A. F. Haddad et al., “Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation,” Arquivos Brasileiros de Cardiologia, vol. 93, no. 4, pp. 372–374, 2009. View at Google Scholar · View at Scopus
  31. D. Sürder, R. Manka, V. Lo Cicero et al., “Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function,” Circulation, vol. 127, no. 19, pp. 1968–1979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. H. Traverse, D. H. McKenna, K. Harvey et al., “Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction,” American Heart Journal, vol. 160, no. 3, pp. 428–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-L. Chen, W.-W. Fang, F. Ye et al., “Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 92–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Quyyumi, E. K. Waller, J. Murrow et al., “CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent,” American Heart Journal, vol. 161, no. 1, pp. 98–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. H. V. Huikuri, K. Kervinen, M. Niemelä et al., “Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction,” European Heart Journal, vol. 29, no. 22, pp. 2723–2732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-W. Lee, S.-H. Lee, Y.-J. Youn et al., “A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction,” Journal of Korean medical science, vol. 29, no. 1, pp. 23–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Ge, Y. Li, J. Qian et al., “Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI),” Heart, vol. 92, no. 12, pp. 1764–1767, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Janssens, C. Dubois, J. Bogaert et al., “Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial,” The Lancet, vol. 367, no. 9505, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R.-C. Huang, K. Yao, Y.-Z. Zou et al., “Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction,” National Medical Journal of China, vol. 86, no. 16, pp. 1107–1110, 2006. View at Google Scholar · View at Scopus
  40. M. Tendera, W. Wojakowski, W. Ruzyłło et al., “Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre myocardial eegeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial,” European Heart Journal, vol. 30, pp. 1313–1321, 2009. View at Google Scholar
  41. J. S. de Lezo, C. Herrera, M. Pan et al., “Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function,” Revista Española de Cardiología, vol. 60, no. 4, pp. 357–365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Wen, C. Z. Pan, G. Q. Huang, Y. L. Li, J. B. Ge, and X. H. Shu, “Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging,” Chinese Medical Journal, vol. 118, no. 14, pp. 1175–1181, 2005. View at Google Scholar
  43. A. Hirsch, R. Nijveldt, P. A. van der Vleuten et al., “Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial,” European Heart Journal, vol. 32, no. 14, pp. 1736–1747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Herbots, J. D'Hooge, E. Eroglu et al., “Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study,” European Heart Journal, vol. 30, no. 6, pp. 662–670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kucia, B. Dawn, G. Hunt et al., “Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction,” Circulation Research, vol. 95, no. 12, pp. 1191–1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Zhang, P. Zhang, J. Guo et al., “Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function,” European Journal of Cardio-Thoracic Surgery, vol. 25, no. 2, pp. 188–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. S. K. Law, C. S.-L. Leung, K. L. Yau et al., “Regulation of multiple transcription factors by reactive oxygen species and effects of pro-inflammatory cytokines released during myocardial infarction on cardiac differentiation of embryonic stem cells,” International Journal of Cardiology, vol. 168, no. 4, pp. 3458–3472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. K. T. Ji, C. Xing, F. Jiang et al., “Benzo[a]pyrene induces oxidative stress and endothelial progenitor cell dysfunction via the activation of the NF-κB pathway,” International Journal of Molecular Medicine, vol. 31, no. 4, pp. 922–930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. C. E. Rochitte, J. A. C. Lima, D. A. Bluemke et al., “Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction,” Circulation, vol. 98, no. 10, pp. 1006–1014, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. P. R. Hansen, “Role of neutrophils in myocardial ischemia and reperfusion,” Circulation, vol. 91, no. 6, pp. 1872–1885, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Yan, A. Anzai, Y. Katsumata et al., “Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 62, pp. 24–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. F. van den Akker, S. C. A. de Jager, and J. P. G. Sluijter, “Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors,” Mediators of Inflammation, vol. 2013, Article ID 181020, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Massa, V. Rosti, M. Ferrario et al., “Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction,” Blood, vol. 105, no. 1, pp. 199–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. Z.-R. Deng, C. Yang, A.-Q. Ma, X.-Y. Chen, and T. Geng, “Dynamic changes of plasma VEGF, SDF-1 and peripheral CD34+ cells in patients with acute myocardial infarction,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 26, no. 11, pp. 1637–1640, 2006. View at Google Scholar · View at Scopus
  55. Q.-C. Guo, Y. Zhang, Y.-F. Wang et al., “Distribution and differentiation of marrow stem cells transplanted by different ways in ischemic myocardium and other organs in rabbits,” Clinical Transplantation, vol. 25, no. 6, pp. 871–877, 2011. View at Publisher · View at Google Scholar · View at Scopus